Promotion of NCI-Black-Reiter male rat bladder carcinogenesis by dimethylarsinic acid an organic arsenic compound

被引:35
作者
Li, W
Wanibuchi, H
Salim, EI
Yamamoto, S
Yoshida, K
Endo, G
Fukushima, S
机构
[1] Osaka City Univ, Sch Med, Dept Pathol 1, Abeno Ku, Osaka 545, Japan
[2] Osaka City Univ, Sch Med, Dept Prevent Med & Environm Hlth, Abeno Ku, Osaka 545, Japan
关键词
dimethylarsinic acid; urinary bladder carcinogenesis; NCI-Black-Reiter rat; alpha; 2u-globulin;
D O I
10.1016/S0304-3835(98)00237-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Dimethylarsinic acid (DMAA) is a major metabolite of inorganic arsenicals in mammals. In the present study, we investigated its promoting effects on urinary bladder carcinogenesis in NCI-Black-Reiter (NBR) rats, which lack alpha 2u-globulin synthesizing ability. Male 9-14-week-old NBR rats were treated sequentially with 0.05% N-butyl-N-(4-hydroxybutyl)-nitrosamine (BBN) for 4 weeks and then given 100 ppm DMAA in their drinking water (group I) for 32 weeks. Induction of preneoplastic lesions (papillary or nodular hyperplasia) in this DMAA-treated group was significantly increased as compared to the carcinogen alone control group (P < 0.01). The development of carcinomas was also enhanced and a significant increase in the 5-bromo-2'-deoxyuridine (BrdU) labeling index of the urinary bladder epithelial cells was observed for the DMAA treatment group. These results indicate that DMAA has promoting effects on urinary bladder carcinogenesis even in NBR rats, so its effects are not dependent on the presence of alpha 2u-globulin. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:29 / 36
页数:8
相关论文
共 50 条
[21]   SPECIES COMPARISON OF THE CONTENT AND COMPOSITION OF URINARY PROTEINS [J].
HARD, GC .
FOOD AND CHEMICAL TOXICOLOGY, 1995, 33 (09) :731-746
[22]   USE OF AVIDIN-BIOTIN-PEROXIDASE COMPLEX (ABC) IN IMMUNOPEROXIDASE TECHNIQUES - A COMPARISON BETWEEN ABC AND UNLABELED ANTIBODY (PAP) PROCEDURES [J].
HSU, SM ;
RAINE, L ;
FANGER, H .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1981, 29 (04) :577-580
[23]  
IARC, 1980, MON EV CARC RISK CHE, V23, P39
[24]   DETERMINATION OF ARSENIC COMPOUNDS USING INDUCTIVELY-COUPLED PLASMA-MASS SPECTROMETRY WITH ION CHROMATOGRAPHY [J].
INOUE, Y ;
KAWABATA, K ;
TAKAHASHI, H ;
ENDO, G .
JOURNAL OF CHROMATOGRAPHY A, 1994, 675 (1-2) :149-154
[25]  
ITO N, 1976, CANCER RES, V36, P2528
[26]  
JOHANSEN MG, 1984, P W PHARMACOL SOC, V27, P289
[27]   INDUCTION OF GENE AMPLIFICATION BY ARSENIC [J].
LEE, TC ;
TANAKA, N ;
LAMB, PW ;
GILMER, TM ;
BARRETT, JC .
SCIENCE, 1988, 241 (4861) :79-81
[28]  
MARIE V, 1981, ENVIRON RES, V25, P286
[29]   ASSESSMENT OF L-ASCORBIC-ACID REQUIREMENT FOR PROLONGED SURVIVAL IN ODS RATS AND THEIR SUSCEPTIBILITY TO URINARY-BLADDER CARCINOGENESIS BY N-BUTYL-N-(4-HYDROXYBUTYL)NITROSAMINE [J].
MORI, S ;
TAKEUCHI, Y ;
TOYAMA, M ;
MAKINO, S ;
HARAUCHI, T ;
KURATA, Y ;
FUKUSHIMA, S .
CANCER LETTERS, 1988, 38 (03) :275-282
[30]   Strain differences in sensitivity to the promoting effect of sodium L-ascorbate in a two-stage rat urinary bladder carcinogenesis model [J].
Murai, T ;
Mori, S ;
Hosono, M ;
Takashima, A ;
Machino, S ;
Oohara, T ;
Yamashita, H ;
Makino, S ;
Matsuda, T ;
Wanibuchi, H ;
Fukushima, S .
JAPANESE JOURNAL OF CANCER RESEARCH, 1997, 88 (03) :245-253